Analysis of Profitability Ratios
Profitability ratios measure the company ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Abbott Laboratories, profitability ratios
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Abbott Laboratories gross profit margin ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 not reaching 2022 level. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Abbott Laboratories operating profit margin ratio deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Abbott Laboratories net profit margin ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level. |
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Abbott Laboratories ROE deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Abbott Laboratories ROA deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level. |
Gross Profit Margin
Abbott Laboratories, gross profit margin calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Gross profit | 21,366) | 20,168) | 22,498) | 22,491) | 17,473) | |
| Net sales | 41,950) | 40,109) | 43,653) | 43,075) | 34,608) | |
| Profitability Ratio | ||||||
| Gross profit margin1 | 50.93% | 50.28% | 51.54% | 52.21% | 50.49% | |
| Benchmarks | ||||||
| Gross Profit Margin, Competitors2 | ||||||
| Cigna Group | 10.15% | 12.37% | 12.44% | 12.41% | 14.43% | |
| CVS Health Corp. | 13.29% | 14.94% | 16.62% | 17.48% | 18.01% | |
| Elevance Health Inc. | 15.92% | 16.79% | 16.79% | 17.09% | 19.71% | |
| Intuitive Surgical Inc. | 67.46% | 66.39% | 67.44% | 69.32% | 65.65% | |
| Medtronic PLC | 65.34% | 65.67% | 67.98% | 65.19% | 67.41% | |
| UnitedHealth Group Inc. | 21.31% | 23.64% | 24.09% | 23.60% | 25.62% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Gross profit margin = 100 × Gross profit ÷ Net sales
= 100 × 21,366 ÷ 41,950 = 50.93%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Abbott Laboratories gross profit margin ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 not reaching 2022 level. |
Operating Profit Margin
Abbott Laboratories, operating profit margin calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Operating earnings | 6,825) | 6,478) | 8,362) | 8,425) | 5,357) | |
| Net sales | 41,950) | 40,109) | 43,653) | 43,075) | 34,608) | |
| Profitability Ratio | ||||||
| Operating profit margin1 | 16.27% | 16.15% | 19.16% | 19.56% | 15.48% | |
| Benchmarks | ||||||
| Operating Profit Margin, Competitors2 | ||||||
| Cigna Group | 3.83% | 4.40% | 4.69% | 4.60% | 5.12% | |
| CVS Health Corp. | 2.30% | 3.85% | 2.41% | 4.54% | 5.19% | |
| Elevance Health Inc. | 4.16% | 4.47% | 4.94% | 5.15% | 4.97% | |
| Intuitive Surgical Inc. | 28.12% | 24.80% | 25.35% | 31.89% | 24.09% | |
| Medtronic PLC | 15.89% | 17.56% | 18.15% | 14.89% | 16.57% | |
| UnitedHealth Group Inc. | 8.17% | 8.80% | 8.83% | 8.40% | 8.76% | |
| Operating Profit Margin, Sector | ||||||
| Health Care Equipment & Services | 5.66% | 6.51% | 6.41% | 6.93% | 7.08% | |
| Operating Profit Margin, Industry | ||||||
| Health Care | 9.19% | 9.87% | 13.87% | 13.77% | 10.81% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Operating profit margin = 100 × Operating earnings ÷ Net sales
= 100 × 6,825 ÷ 41,950 = 16.27%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Abbott Laboratories operating profit margin ratio deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024. |
Net Profit Margin
Abbott Laboratories, net profit margin calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net earnings | 13,402) | 5,723) | 6,933) | 7,071) | 4,495) | |
| Net sales | 41,950) | 40,109) | 43,653) | 43,075) | 34,608) | |
| Profitability Ratio | ||||||
| Net profit margin1 | 31.95% | 14.27% | 15.88% | 16.42% | 12.99% | |
| Benchmarks | ||||||
| Net Profit Margin, Competitors2 | ||||||
| Cigna Group | 1.40% | 2.66% | 3.72% | 3.11% | 5.31% | |
| CVS Health Corp. | 1.24% | 2.34% | 1.29% | 2.72% | 2.68% | |
| Elevance Health Inc. | 3.41% | 3.52% | 3.87% | 4.46% | 3.78% | |
| Intuitive Surgical Inc. | 27.81% | 25.24% | 21.25% | 29.85% | 24.33% | |
| Medtronic PLC | 11.36% | 12.03% | 15.90% | 11.97% | 16.56% | |
| UnitedHealth Group Inc. | 3.65% | 6.09% | 6.25% | 6.06% | 6.03% | |
| Net Profit Margin, Sector | ||||||
| Health Care Equipment & Services | 3.77% | 4.56% | 4.74% | 5.08% | 5.27% | |
| Net Profit Margin, Industry | ||||||
| Health Care | 6.24% | 8.47% | 10.73% | 11.32% | 8.06% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Net profit margin = 100 × Net earnings ÷ Net sales
= 100 × 13,402 ÷ 41,950 = 31.95%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Abbott Laboratories net profit margin ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level. |
Return on Equity (ROE)
Abbott Laboratories, ROE calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net earnings | 13,402) | 5,723) | 6,933) | 7,071) | 4,495) | |
| Total Abbott shareholders’ investment | 47,664) | 38,603) | 36,686) | 35,802) | 32,784) | |
| Profitability Ratio | ||||||
| ROE1 | 28.12% | 14.83% | 18.90% | 19.75% | 13.71% | |
| Benchmarks | ||||||
| ROE, Competitors2 | ||||||
| Cigna Group | 8.37% | 11.17% | 14.86% | 11.39% | 16.81% | |
| CVS Health Corp. | 6.11% | 10.91% | 5.84% | 10.54% | 10.35% | |
| Elevance Health Inc. | 14.47% | 15.23% | 16.59% | 16.93% | 13.77% | |
| Intuitive Surgical Inc. | 14.13% | 13.51% | 11.98% | 14.32% | 10.90% | |
| Medtronic PLC | 7.32% | 7.30% | 9.59% | 7.01% | 9.44% | |
| UnitedHealth Group Inc. | 15.55% | 25.22% | 25.87% | 24.09% | 23.52% | |
| ROE, Sector | ||||||
| Health Care Equipment & Services | 13.11% | 15.01% | 15.22% | 14.90% | 14.75% | |
| ROE, Industry | ||||||
| Health Care | 14.41% | 18.07% | 22.47% | 22.98% | 16.02% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
ROE = 100 × Net earnings ÷ Total Abbott shareholders’ investment
= 100 × 13,402 ÷ 47,664 = 28.12%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Abbott Laboratories ROE deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level. |
Return on Assets (ROA)
Abbott Laboratories, ROA calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net earnings | 13,402) | 5,723) | 6,933) | 7,071) | 4,495) | |
| Total assets | 81,414) | 73,214) | 74,438) | 75,196) | 72,548) | |
| Profitability Ratio | ||||||
| ROA1 | 16.46% | 7.82% | 9.31% | 9.40% | 6.20% | |
| Benchmarks | ||||||
| ROA, Competitors2 | ||||||
| Cigna Group | 2.20% | 3.38% | 4.63% | 3.46% | 5.44% | |
| CVS Health Corp. | 1.82% | 3.34% | 1.82% | 3.39% | 3.11% | |
| Elevance Health Inc. | 5.12% | 5.50% | 5.86% | 6.26% | 5.28% | |
| Intuitive Surgical Inc. | 12.39% | 11.64% | 10.19% | 12.58% | 9.50% | |
| Medtronic PLC | 4.09% | 4.13% | 5.54% | 3.87% | 5.28% | |
| UnitedHealth Group Inc. | 4.83% | 8.18% | 8.19% | 8.15% | 7.81% | |
| ROA, Sector | ||||||
| Health Care Equipment & Services | 4.72% | 5.51% | 5.59% | 5.58% | 5.44% | |
| ROA, Industry | ||||||
| Health Care | 5.03% | 6.47% | 8.43% | 8.29% | 5.45% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
ROA = 100 × Net earnings ÷ Total assets
= 100 × 13,402 ÷ 81,414 = 16.46%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Abbott Laboratories ROA deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level. |